期刊文献+

丁酸通过下调HMGB1抑制高糖诱导下结肠上皮细胞NCM460的异常增殖 被引量:3

Butyrate suppresses abnormal proliferation of colonic epithelial NCM460 cells induced by high glucose by down-regulating HMGB1
下载PDF
导出
摘要 目的观察丁酸对高葡萄糖诱导下结肠上皮细胞NCM460增殖的影响,探讨高迁移率族蛋白1(HMGB1)/晚期糖基化终产物受体(RAGE)通路在其中的作用。方法用33 mmol/L D-葡萄糖诱导正常人结肠细胞系NCM460,并予4 mmol/L丁酸干预,通过实时荧光定量PCR、蛋白免疫印迹法、细胞免疫荧光及ELISA检测细胞HMGB1和RAGE的表达情况。测定增殖细胞核抗原(PCNA)表达量和细胞增殖的情况。过表达及下调NCM460的HMGB1,观察HMGB1对细胞表达RAGE及增殖的调控作用。结果高糖诱导下,NCM460细胞增殖能力增高,HMGB1和RAGE的表达升高,细胞上清中HMGB1的含量亦增加(P均<0.001)。予丁酸处理,NCM460细胞异常增殖受抑制且HMGB1和RAGE的表达下降(P均<0.001)。过表达HMGB1可上调RAGE的表达并逆转丁酸对异常增殖的抑制作用,而下调HMGB1表达可抑制RAGE的表达,抑制异常增殖(P均<0.05)。结论高糖诱导下的NCM460存在增殖异常,HMGB1和RAGE表达增加。丁酸通过下调HMGB1/RAGE通路,抑制高糖诱导下NCM460的异常增殖。 Objective To observe the effect of butyrate on the proliferation of colonic epithelial NCM460 cells induced by high glucose and to explore the role of high-mobility group box 1 protein(HMGB1)/the receptor for advanced glycation end products(RAGE)pathway during this process.Methods The normal human colonic cell lines NCM460 were induced by D-glucose at a dosage of 33 mmol/L and treated with butyrate at a dose of 4 mmol/L.The expression levels of HMGB1 and RAGE in the treated NCM460 cells were quantitatively measured by real-time fluorescent quantitative PCR(RT-qPCR),western blot analysis,immunofluorescent staining.The expression level of proliferating cell nuclear antigen(PCNA)was measured and the cell proliferation was investigated.The level of HMGB1 was over-expressed and down-regulated in NCM460 cells.The effect of HMGB1 upon the expression level of RAGE and the proliferation of NCM460 cells was assessed.Results Under high-glucose induction,the proliferation of NCM460 cells was accelerated,the expression levels of HMGB1 and RAGE were significantly up-regulated and the content of HMGB1 was considerably elevated in the NCM460 cells(all P<0.001).After butyrate treatment,the abnormal proliferation of NCM460 cells was effective suppressed and the expression levels of HMGB1 and RAGE were significantly down-regulated(all P<0.001).Over-expression of HMGB1 could up-regulate the expression of RAGE and reverse the inhibitory effect of butyrate on abnormal cellular proliferation,whereas down-regulation of HMGB1 expression could inhibit the expression of RAGE and suppress abnormal cellular proliferation(all P<0.05).Conclusions Under high-glucose induction,abnormal proliferation of NCM460 cells is observed,and the expression levels of HMGB1 and RAGE are up-regulated.Butyrate can suppress the hyperglycemia-induced abnormal proliferation of NCM460 cells by down-regulating the HMGB1/RAGE signaling pathway.
作者 王思仪 黎洁瑶 于涛 许稷豪 陈其奎 夏忠胜 Wang Siyi;Li Jieyao;Yu Tao;Xu Jihao;Chen Qikui;Xia Zhongsheng(Department of Gastroenterology,Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Guangzhou 510120,China)
出处 《新医学》 2018年第4期234-240,共7页 Journal of New Medicine
基金 广东省自然科学基金(2014A030310041)
关键词 丁酸 高糖 NCM460细胞 增殖 高迁移率族蛋白B1 Butyrate High glucose NCM460 cell Proliferation High-mobility group box 1 protein
  • 相关文献

参考文献3

二级参考文献67

  • 1Meetings[J].World Journal of Gastroenterology,2010,16(1). 被引量:25
  • 2Sofia Tedelind,Fredrik Westberg,Martin Kjerrulf,Alexander Vidal.Anti-inflammatory properties of the short-chain fatty acids acetate and propionate:A study with relevance to inflammatory bowel disease[J].World Journal of Gastroenterology,2007,13(20):2826-2832. 被引量:82
  • 3Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59:366-378.
  • 4Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.
  • 5Swerdlow AJ, Laing SF, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gaffing W, Gale EA, Patterson CC, Keen H. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005; 92:2070-2075.
  • 6Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89:1360-1365.
  • 7Ogunleye AA, Ogston SA, Morris AD, Evans JM. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009; 101:1199-1201.
  • 8Smith CJ, McKay GA, Fisher M. Diabetes, colorectal cancer and cydooxygenase 2 inhibition. Int J Clin Pract 2008; 62:810-815.
  • 9Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type I diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95:1797-1800.
  • 10Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ 3rd, Sellers TA, Cerhan JR. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 2006; 101:1872-1879.

共引文献35

同被引文献6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部